pharmaceutical

Medications for alcohol use disorder: the time is now

Needle-free adrenaline wins FDA green light

NT looks to follow QLD’s lead on pharmacy

JAK inhibitor helps beat infantile bullous pemphigoid

Call for calm over topical steroid withdrawal reports

Opioids on the silver screen

Under half of fibromyalgia patients use evidence-based drugs

Fresh call to up-schedule modified-release paracetamol
